EPICOS Clinical Trial for the Prevention of Infection in Healthcare Personnel
Status:
Active, not recruiting
Trial end date:
2020-07-31
Target enrollment:
Participant gender:
Summary
Having healthcare professionals affected by SARS-CoV-2 is especially relevant for several
reasons. Where incidence of COVID-19 is high, participation of healthcare workers is required
to be able to attend the care needs present. Sick leave and the need for isolation during 14
days dwindles the already scarce human resources available to fight the epidemic. In
addition, the healthcare professionals developing asymptomatic illness could inadvertently
transmit the virus to the patients being attended, contributing in this way to maintaining
the epidemic among the most vulnerable population.
Phase:
Phase 3
Details
Lead Sponsor:
Effice Servicios Para la Investigacion S.L.
Collaborator:
Plan Nacional sobre el Sida PNS. Ministerio de Sanidad (Sponsor)
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Hydroxychloroquine Tenofovir